Related Experiment Video
Updated: Aug 10, 2025

04:48
Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
2.9K
Evaluation of the HD-GLIO Deep Learning Algorithm for Brain Tumour Segmentation on Postoperative MRI
Peter Jagd Sørensen1,2,3, Jonathan Frederik Carlsen1,2, Vibeke Andrée Larsen1
1Department of Radiology, Centre of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Diagnostics (Basel, Switzerland)
|February 11, 2023
Summary
This study evaluated the HD-GLIO deep learning algorithm for brain tumor segmentation. While effective for non-enhancing and large enhancing tumors, its performance significantly dropped for smaller enhancing lesions.
Area of Science:
- Radiology
- Artificial Intelligence
- Medical Imaging
Background:
- Deep learning for 3D brain tumor segmentation shows promise for routine radiological workflows.
- Accurate segmentation is crucial for assessing treatment response in brain tumors.
Purpose of the Study:
- To externally evaluate the HD-GLIO deep learning algorithm's performance on an independent cohort of post-operative patients.
- To assess the algorithm's accuracy in segmenting contrast-enhancing (CE) and non-enhancing (NE) brain tumor lesions.
Main Methods:
- Compared HD-GLIO segmentations with radiologist delineations on 66 MRI scans.
- Utilized Dice similarity coefficients (Dice) for segmentation accuracy and concordance correlation coefficients (CCCs) for volume agreement.
Main Results:
- HD-GLIO achieved high performance for NE volumes (median Dice = 0.79) and large CE tumor volumes (>1.0 cm³; median Dice = 0.86).
- Performance significantly decreased for all CE tumor lesions (median Dice = 0.40).
- Excellent volume agreement was observed (CCCs of 0.997 for CE, 0.922 for NE).
Conclusions:
- The HD-GLIO algorithm shows potential but requires further validation, especially for small contrast-enhancing tumors in routine clinical use.
- Independent validation on diverse clinical datasets is essential to confirm the robustness of deep learning segmentation algorithms.

